Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 813-050-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Assessment of Preferential T-Helper 1 or T-Helper 2 Induction by Low Molecular Weight Compounds Using the Local Lymph Node Assay in Conjunction with RT-PCR and ELISA for Interferon-g and Interleukin-4
- Author:
- Van de Briel, R.J., De Jong, W.H., Spiekstra, S.W., Van Dijk, M., Fluitman, A., Garssen, J. and Van Loveren, H.
- Year:
- 2 000
- Bibliographic source:
- Toxicology and Applied Pharmacology 162, 77–85 (2000)
Materials and methods
- Principles of method if other than guideline:
- The aim of the study was to establish whether the LLNA was sufficient to not only identify allergens but also mark them as either a contact or a respiratory allergen. To this end, IFN-g and IL-4 mRNA expression as well as the production of these cytokines was measured at various time points after primary sensitization with DNCB and TMA. In a second study, production of IFN-g and IL-4 was measured after primary sensitization with DNCB and TMA, as well as the respiratory sensitizers toluene-2,4-diisocyanate (TDI) and phthalic anhydride (PA).
- GLP compliance:
- not specified
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Toluene diisocyanate
- IUPAC Name:
- Toluene diisocyanate
- Details on test material:
- - Name of test material (as cited in study report): toluene-2,4-diisocyanate (TDI; 99.8% purity),
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- Balb/c
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: obtained from own breeding colony, or from Harlan/CPB, Zeist, The Netherlands
- Age at study initiation: 6–8 weeks
- Diet (e.g. ad libitum): ground standard laboratory chow (RMH-B, Hope Farms, Woerden, The Netherlands) ad libitum
- Water (e.g. ad libitum): ad libitum
- Other: The breeding colony of the animals was pre-screened/monitored for endogenous pathogenic viruses and bacteria and was found negative.
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 0.75% (w/v) for TDI
- No. of animals per dose:
- 4-8 animals (differing depending on the type of experiment conducted)
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility:
- Irritation:
- Lymph node proliferation response:
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method:
- Criteria used to consider a positive response:
TREATMENT PREPARATION AND ADMINISTRATION:
For three consecutive days, 25 µl of 1% DNCB, 12.5% TMA, and AOO (first study) or 1% DNCB, 10% TMA, 0.75% TDI, 25% PA, and AOO (second study) were applied to the dorsum of both ears. At various days after the last application, the local (auricular) lymph nodes (LN) were excised and weighed. For RT-PCR, they were snap-frozen in liquid nitrogen and stored at 270°C. For the lymphocyte proliferation test and ELISA, local LN cell suspensions were made. - Statistics:
- Statistical analysis was performed using the two-tailed Student’s t test.
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: no data available
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: no data available
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Criteria used for interpretation of results: EU-GHS
- Conclusions:
- The publication is based on experiments according to the local lymph node assay, and was conducted to not only identify allergens but also mark them as either a contact or a respiratory allergen and is considered to be of high quality (reliability Klimisch 2). The validity criteria of the test system are fulfilled. The test material did induce sensitisation and should be classified accordingly.
- Executive summary:
Vandebriel and co-workers investigated whether the LLNA was sufficient to not only identify allergens but also mark them as either a contact or a respiratory allergen (Vandebriel et al., 2000). It has been shown that contact allergens preferentially induce a T-helper 1 (TH1) response, whereas respiratory allergens preferentially induce a T-helper 2 (TH2) response. These responses can be discriminated on the basis of cytokine production, such as IFN-g, which is produced by TH1 cells, and IL-4, which is produced by TH2 cells. To this end, IFN-g and IL-4 mRNA expression as well as the production of these cytokines was measured at various time points after primary sensitisation with DNCB and TMA. In a second study, production of IFN-g and IL-4 was measured after primary sensitization with DNCB and TMA, as well as the respiratory sensitizers toluene-2,4-diisocyanate (TDI) and phthalic anhydride (PA); these two were assayed 7 days after the first application. Topical application of DNCB and TMA for three consecutive days does not induce IFN-g mRNA expression relative to the vehicle control, and similarly induces IL-4 mRNA expression. While application of DNCB and PA results in a similar proliferative response, PA induces 16-fold more IL-4 (and fourfold less IFN-g). Furthermore, while application of TMA and TDI results in a 1.8-fold larger proliferative response compared to DNCB, 15- to 30-fold more IL-4 is produced (and similar amounts of IFN-g). Thus, TMA, TDI, and PA can be discriminated from DNCB on the basis of IL-4 production within the LLNA. IFN-g production was similar for DNCB, TMA, and TDI, and fourfold lower for PA, while IL-4 production was similar for TMA, TDI, and PA, and 24-fold lower for DNCB.
In summary, both studies showed induction of IL-4 production by respiratory allergens, with little or no induction by the contact allergen, holding promise for the possibility of identifying allergens (based on lymphocyte proliferation) and respiratory allergens within the LLNA by measuring IL-4 production 7 days after the first application.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.